VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CHRS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CHRSCoherus Oncology, Inc.
$1.67$204M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCHRSQuarterly Financials

Coherus Oncology, Inc. (CHRS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Coherus Oncology, Inc. (CHRS) quarterly income statement — complete revenue, gross profit & net income history

CHRS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue12.31M12.75M11.57M10.25M7.6M54.14M70.77M64.98M2.31M91.52M74.57M58.72M32.44M45.35M45.42M60.15M60.12M73.37M82.5M87.64M
Revenue Growth %61.99%-76.46%-83.65%-84.22%229.25%-40.84%-5.09%10.67%-92.88%101.81%64.16%-2.39%-46.04%-38.19%-44.94%-31.37%-27.6%-33.55%-27.34%-35.4%
Cost of Goods Sold4.7M4.94M4.69M4.41M3.7M33.86M20.74M29.55M1.44M84.57M32.7M24.85M16.87M14.2M35.23M11.28M9.37M12.1M21.28M16.7M
COGS % of Revenue38.14%38.76%40.51%43.02%48.68%62.53%29.31%45.48%62.35%92.4%43.86%42.32%52.02%31.31%77.57%18.75%15.59%16.5%25.79%19.05%
Gross Profit7.62M7.81M6.88M5.84M3.9M20.29M50.03M35.42M869K6.96M41.87M33.87M15.56M31.15M10.19M48.87M50.74M61.27M61.22M70.95M
Gross Margin %61.86%61.24%59.49%56.98%51.32%37.47%70.69%54.52%37.65%7.6%56.14%57.68%47.98%68.69%22.43%81.25%84.41%83.5%74.21%80.95%
Gross Profit Growth %95.26%-61.52%-86.24%-83.51%348.79%191.59%19.51%4.59%-94.42%-77.67%310.84%-30.7%-69.33%-49.16%-83.36%-31.11%-32.81%-37.95%-41.44%-43.48%
Operating Expenses43.77M53.69M49.12M51.33M49.34M62.53M56.42M55.93M68.66M75.86M73.87M68.41M83.31M82.64M90.64M92.89M131.67M100.81M94.01M95.11M
OpEx % of Revenue355.53%421.14%424.48%500.58%649.23%115.49%79.72%86.08%2974.7%82.89%99.07%116.51%256.84%182.23%199.54%154.42%219.03%137.4%113.95%108.52%
Selling, General & Admin23.1M23.61M22.83M26.04M26.02M41.3M34.74M35.16M40.23M49.49M48.22M45.14M49.15M53.62M44.83M51.28M48.75M50.05M39.92M40.34M
SG&A % of Revenue187.68%185.2%197.31%253.94%342.48%76.27%49.09%54.12%1743.15%54.08%64.67%76.89%151.54%118.23%98.69%85.25%81.1%68.22%48.39%46.03%
Research & Development20.66M30.08M26.29M25.29M23.31M21.23M21.68M20.77M28.42M26.37M25.65M23.27M34.15M29.02M45.81M41.61M82.92M50.76M54.09M54.77M
R&D % of Revenue167.85%235.94%227.17%246.64%306.75%39.22%30.63%31.96%1231.54%28.81%34.39%39.63%105.3%63.99%100.85%69.18%137.93%69.19%65.56%62.49%
Other Operating Expenses00000000000000000000
Operating Income-36.15M-45.88M-42.23M-45.49M-45.44M-42.25M-6.39M-20.51M-67.79M-68.91M-32.01M-34.54M-67.75M-51.49M-80.45M-44.01M-80.92M-39.55M-32.79M-24.16M
Operating Margin %-293.67%-359.9%-364.99%-443.59%-597.91%-78.03%-9.02%-31.56%-2937.05%-75.29%-42.92%-58.83%-208.86%-113.54%-177.11%-73.17%-134.62%-53.9%-39.74%-27.57%
Operating Income Growth %20.43%-8.6%-561.23%-121.79%32.97%38.69%80.04%40.63%-0.06%-33.81%60.22%21.52%16.29%-30.21%-145.37%-82.14%51.65%-340.77%-197.24%-137%
EBITDA-35.27M-44.98M-41.27M-44.47M-44.39M-41.21M-4.84M-19.32M-66.28M-67.84M-30.37M-33.66M-66.8M-50.44M-79.45M-43.13M-80.16M-38.71M-31.89M-23.29M
EBITDA Margin %-286.51%-352.87%-356.64%-433.68%-584.14%-76.12%-6.84%-29.74%-2871.75%-74.12%-40.73%-57.33%-205.93%-111.23%-174.92%-71.7%-133.34%-52.76%-38.66%-26.57%
EBITDA Growth %20.54%-9.15%-752.98%-130.15%33.03%39.25%84.07%42.6%0.77%-34.49%61.78%21.94%16.67%-30.31%-149.11%-85.19%51.86%-324.22%-192.69%-135.25%
D&A (Non-Cash Add-back)881K896K966K1.02M1.05M1.03M1.55M1.19M1.51M1.06M1.64M880K949K1.05M995K887K767K836K892K877K
EBIT-36.15M-45.88M-42.23M-45.49M-45.44M-45.35M-5.39M-7.59M-64.92M-69.03M-29.75M-32.93M-66.02M-49.48M-79.11M-43.57M-87.11M-39.93M-32.76M-24.15M
Net Interest Income-2.19M-2.25M-2.33M-2.28M-2.15M-5.35M-5.36M-5.33M-11.12M-10.62M-10.27M-9.94M-9.71M-9.38M-7.54M-6.58M-8.97M-5.79M-5.77M-5.75M
Interest Income00000000000000000000
Interest Expense2.19M2.25M2.33M2.28M2.15M5.35M5.36M5.33M11.12M10.62M10.27M9.94M9.71M9.38M7.54M6.58M8.97M5.79M5.77M5.75M
Other Income/Expense-784K-467K-2.28M624K-1.96M-8.45M-4.36M7.59M-249K-10.75M-8.02M-8.33M-7.98M-7.38M-6.2M-6.14M-15.16M-6.18M-5.74M-5.74M
Pretax Income-36.94M-46.35M-44.52M-44.86M-47.4M-50.7M-10.75M-12.92M-68.04M-79.65M-40.02M-42.87M-75.73M-58.87M-86.65M-50.15M-96.08M-45.73M-38.53M-29.9M
Pretax Margin %-300.04%-363.56%-384.73%-437.51%-623.74%-93.63%-15.19%-19.88%-2947.83%-87.03%-53.67%-73.01%-233.47%-129.81%-190.76%-83.37%-159.83%-62.32%-46.7%-34.12%
Income Tax0000000000-380K000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0.95%0%0%0%0%0%0%0%0%0%
Net Income-37.94M-37.28M-35.11M-41.34M-56.57M-50.7M-10.75M-12.92M102.88M-79.65M-39.64M-42.87M-75.73M-58.87M-86.65M-50.15M-96.08M-45.73M-38.53M-29.9M
Net Margin %-308.2%-292.42%-303.42%-403.11%-744.43%-93.63%-15.19%-19.88%4457.32%-87.03%-53.16%-73.01%-233.47%-129.81%-190.76%-83.37%-159.83%-62.32%-46.7%-34.12%
Net Income Growth %32.93%26.47%-226.56%-219.91%-154.99%36.35%72.88%69.86%235.85%-35.3%54.25%14.52%21.18%-28.75%-124.9%-67.73%44.44%-571%-237.93%-150.65%
Net Income (Continuing)-36.94M-46.35M-44.52M-44.86M-47.4M-50.7M-10.75M-12.92M-68.04M-79.65M-39.64M-42.87M-75.73M-58.87M-86.65M-50.15M-96.08M-45.73M-38.53M-29.9M
Discontinued Operations-1000K1000K1000K1000K-1000K0001000K00000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.28-0.31-0.30-0.39-0.49-0.44-0.09-0.110.82-0.71-0.41-0.49-0.94-0.85-1.19-0.73-1.44-0.60-0.49-0.40
EPS Growth %42.86%29.55%-221.54%-254.55%-159.76%38.03%77.24%77.55%187.23%16.47%65.55%32.88%34.72%-41.67%-142.86%-82.5%39.24%-600%-248.48%-157.14%
EPS (Basic)-0.28-0.31-0.30-0.39-0.49-0.44-0.09-0.110.91-0.71-0.41-0.49-0.94-0.85-1.19-0.73-1.44-0.60-0.49-0.40
Diluted Shares Outstanding136.4M120.37M116.23M116.08M115.86M115.42M115.21M114.82M125.53M111.49M97.74M87.27M79.27M77.96M77.75M77.55M77.25M76.83M79.01M75.56M
Basic Shares Outstanding136.4M120.37M116.23M116.08M115.86M115.42M115.21M114.82M112.75M111.49M97.74M87.27M79.27M77.96M77.75M77.15M77.25M76.35M78.63M75.56M
Dividend Payout Ratio--------------------